MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
The Associate Director, Marketing will serve as the commercial lead for Hepatitis Delta (HDV) diagnostics and patient finding, with responsibility for building scalable capabilities that increase testing, identify undiagnosed patients, understand ‘diagnostic leakage’ and improve the pathway from diagnosis through referral to appropriate care.
This role will focus on building sustainable patient-identification infrastructure across the HDV diagnostic and referral systems helping translate pre-launch investment into a more visible, connected and launch-ready patient population. The Associate Director will lead commercial initiatives designed to increase HDV testing, expand appropriate reflex and double-reflex testing approaches, reduce barriers within the diagnostic journey, and accelerate identification of patients living with HDV.
The Associate Director will serve as a key leader in U.S. HDV market development, identifying structural barriers to diagnosis and developing scalable solutions that improve patient identification and strengthen diagnostic and referral pathways. Working closely with Brand Marketing, Medical Affairs, Advocacy, Commercial Analytics, Field Teams, Market Access, and other cross-functional partners, the Associate Director will translate market, customer, diagnostic, and community insights into actionable programs. The role will also build strategic partnerships with diagnostic laboratories, health systems, community organizations, and other external stakeholders to develop and scale innovative approaches to patient identification.
This role is ideal for a strategic, entrepreneurial, analytical, and highly collaborative professional who is comfortable building new capabilities, testing innovative approaches, and driving initiatives from strategy through execution and measurement.
JOB FUNCTIONS/RESPONSIBILITIES
- Develop and maintain a multi-year HDV patient-identification and diagnostics roadmap, prioritizing initiatives based on patient impact, scalability, feasibility, investment requirements, and contribution to U.S. launch readiness.
- Lead the development and execution of the U.S. commercial diagnostics and patient-finding strategy for HDV, with accountability for increasing testing, diagnosis, and linkage to appropriate care.
- Develop implementation frameworks that enable health systems and laboratory partners to operationalize and sustain appropriate HDV testing pathways, including workflow redesign, stakeholder engagement, education, technology enablement and performance measurement.
- Lead commercial initiatives designed to increase adoption of appropriate HDV testing approaches, including reflex and double-reflex testing within health systems and laboratory workflows.
- Build and manage strategic partnerships with national and regional diagnostic laboratories, health systems, and other testing organizations to expand access to and simplify HDV testing.
- Identify barriers and develop scalable diagnostic solutions that improve testing workflows and enable more consistent identification of patients with HDV.
- Lead innovative patient-finding pilots utilizing appropriate data and technology, including electronic medical records, claims data, population-health approaches, and other emerging capabilities.
- Partner with Commercial Analytics to identify geographic, demographic, health-system, and provider opportunities for increased HDV testing and diagnosis.
- Develop and execute community activation strategies focused on populations and geographies with elevated potential burden of HDV.
- Build partnerships in collaboration with patient advocacy with community organizations, healthcare systems, and other appropriate stakeholders to develop culturally relevant disease education, testing, and linkage-to-care initiatives.
- Translate diagnostic, field, customer, and community insights into actionable commercial strategies and programs.
- Develop annual operating plans and manage budgets for diagnostics, patient-finding initiatives, pilots, partnerships, agencies, and external vendors, ensuring investments are prioritized against strategic objectives and measurable outcomes.
- Develop tools, resources, and initiatives that support appropriate HDV testing consistent with applicable clinical recommendations and testing pathways
- Partner closely with Field Teams to identify local testing barriers and opportunities and develop scalable solutions that support patient identification.
- Collaborate with Medical Affairs, Advocacy, Market Access, Commercial Operations and other cross-functional stakeholders to ensure alignment and effective execution of diagnostics and community priorities.
- Establish clear objectives and appropriate leading and lagging performance measures for diagnostics and patient-finding programs, including testing adoption, workflow implementation, diagnostic completion, referral pathway effectiveness, time to diagnosis/referral, program reach, sustainability, scalability, and other appropriate measures, in partnership with Analytics and relevant governance functions.
- Analyze program performance and continuously optimize strategies based on data, market insights, customer feedback, and pilot learnings.
- Create and identify successful pilot programs and develop approaches for scaling them across priority markets, health systems, and communities.
- Contribute U.S. market insights and best practices to broader regional and global diagnostic planning and capability development.
- Manage agencies, vendors, diagnostic partners, and other external organizations, ensuring high-quality, compliant, and timely delivery of initiatives.
- Ensure all programs and partnerships are developed and executed in accordance with applicable regulatory, legal, privacy, and compliance requirements. Ensure patient-finding initiatives utilizing claims, EMR, laboratory, population-health, or other healthcare data are designed and executed in accordance with applicable privacy requirements, data-use agreements, company policies, and appropriate Legal and Compliance guidance.
QUALIFICATIONS
Education /Experience:
- Bachelor’s degree in business, marketing, life sciences, public health, healthcare, or a related field required; advanced degree preferred.
- 7+ years of experience in pharmaceutical, biotechnology, diagnostics, healthcare, or related industry.
- Demonstrated experience developing and implementing diagnostic, patient-identification, population-health, or healthcare-system initiatives involving laboratories, health systems, provider networks, or healthcare data strongly preferred.
- Experience navigating complex healthcare-system implementation processes, including laboratory workflows, EMR/LIS-enabled solutions, population-health programs, or clinical workflow redesign preferred
- Experience in rare disease, hepatology, infectious disease, specialty medicine, or another underdiagnosed disease area preferred.
- Experience developing external partnerships with diagnostic laboratories, healthcare systems, advocacy organizations, or community organizations is highly desirable.
Knowledge and Skills:
- Applies strategic thinking to translate complex diagnostic, patient journey, and market challenges into actionable commercial strategies and priorities.
- Demonstrates strong systems thinking and the ability to understand interconnected barriers across diagnostic, laboratory, health-system, referral, community, and patient pathways and translate them into coordinated solutions.
- Develops compelling business cases for investment, using market opportunity, patient impact, operational feasibility, scalability, financial considerations, and measurable outcomes to inform prioritization and resource allocation
- Maintains a strong customer and patient orientation and translates market, diagnostic, field, and community insights into impactful initiatives.
- Brings creativity and innovative thinking, challenges the status quo, and is comfortable developing new approaches where established models may not exist.
- Applies an analytical mindset to synthesize data and insights, identify patient-finding opportunities, evaluate program performance, and inform investment decisions.
- Works effectively in a matrix organization and builds strong relationships across Marketing, Medical Affairs, Advocacy, Field Teams, Market Access, Commercial Analytics, Legal/Compliance, and other functions.
- Demonstrates the ability to build and influence productive relationships with external partners, including diagnostic laboratories, healthcare systems, vendors, and community organizations.
- Possesses strong organizational and project-management skills, with the ability to manage multiple complex workstreams, pilots, external partners, and deadlines.
- Demonstrates strong communication, presentation, and influencing skills and is comfortable engaging with senior internal and external stakeholders.
- Is digitally fluent and comfortable working with data, analytics platforms, digital tools, EMR-based approaches, and emerging patient-finding technologies.
- Takes initiative, demonstrates accountability, and drives assigned programs from strategy through execution, measurement, optimization, and scale.
- Collaborates effectively across functions and thrives in a dynamic, fast-paced, entrepreneurial environment.
- Demonstrates sound judgment and an understanding of the regulatory, legal, privacy, and compliance considerations associated with diagnostics and patient-finding programs.
- Ability to travel 30%
The salary range for this position is $215,000 to $230,000 USD. Compensation will be determined based on several factors including, but not limited to; skill set, years of experience, and the employee’s geographic location. Please note that the required compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits unless otherwise provided.
#LI-HYBRID
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Skills Required
- Bachelor’s degree in business, marketing, life sciences, public health, healthcare, or a related field
- 7+ years of experience in pharmaceutical, biotechnology, diagnostics, healthcare, or a related industry
- Ability to travel 30%
- Advanced degree
- Experience developing and implementing diagnostic, patient-identification, population-health, or healthcare-system initiatives involving laboratories, health systems, provider networks, or healthcare data
- Experience with laboratory workflows, EMR/LIS-enabled solutions, population-health programs, or clinical workflow redesign
- Experience in rare disease, hepatology, infectious disease, specialty medicine, or another underdiagnosed disease area
- Experience developing partnerships with diagnostic laboratories, healthcare systems, advocacy organizations, or community organizations
Mirum Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Mirum Pharmaceuticals and has not been reviewed or approved by Mirum Pharmaceuticals.
-
Equity Value & Accessibility — Equity grants to new hires and an employee stock purchase plan make ownership more accessible and can boost total rewards when performance is strong. Public disclosures highlight frequent option/RSU inducements.
-
Healthcare Strength — Comprehensive medical, dental, and vision coverage is employer-paid for employees, with added life, disability, and EAP support. This combination reduces financial burden and enhances overall wellbeing.
-
Leave & Time Off Breadth — A broad time-off program includes multiple paid company holidays, a year-end shutdown, accrued vacation, and paid parental leave. This breadth provides additional rest periods beyond standard vacation.
Mirum Pharmaceuticals Insights
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome. Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome. Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.








